Among the sub-group of patients with uterine cancer, PVs were identified in (12/76; 15.7%) MMR genes, as well as BRCA2, ATM, RAD51C, and NTHL1. Out of 24 patients with pancreatic cancer, two patients tested positive for a PV in the PALB2 gene accounting for an 8.3% PV detection rate. This evidence concerns the gene BRCA2 and familial pancreatic carcinoma.